#USA #Redwood City #LYNX #Norlase #Ophthalmoscope

Norlase Unveils LYNX™: Advancing Ophthalmic Technology

Norlase, a premier global manufacturer of cutting-edge laser solutions for ophthalmology, has made a significant leap in eye care technology with the launch of its latest innovation, the LYNX™ laser indirect ophthalmoscope (LIO). On January 27, 2025, the company proudly announced that the LYNX™ has received both the FDA 510(k) clearance and CE marking, making it the world's first and only laser indirect ophthalmoscope equipped with a pattern-scanning capability.

A Game-Changer in Ophthalmic Treatments

The introduction of LYNX™ promises to reshape the way ophthalmologists conduct indirect laser treatments. This state-of-the-art device is battery-operated, offering unprecedented portability and flexibility in treatment environments. Unlike traditional systems that require external power sources, the integrated laser and pattern module within the ergonomic headset allows surgeons to move freely and efficiently during procedures—a critical advancement in enhancing the overall treatment experience for both doctors and patients.

As Oliver Hvidt, the CEO and co-founder of Norlase, highlights, "The most valuable resource for today's ophthalmologist is time." With the advent of LYNX™, practitioners can expect quicker indirect laser treatments that result in reduced ergonomic strain, providing them with more quality time for patient consultations and improving the overall workflow. This marks Norlase's fourth product launch in just five years, demonstrating the company's commitment to innovating and streamlining ophthalmologic practices while enhancing both comfort and efficiency.

Features and User Feedback

The LYNX™ is equipped with a plethora of advanced features designed to optimize treatments:

• - Integrated System: The laser, scanner, and delivery system are fully embedded within an ultra-lightweight headset, making it exceptionally portable.
• - Full Pattern Selection: Offers a comprehensive range of patterns, including grid options from 2x2 to 5x5, as well as triple arches and circles.
• - SimplyCLEAR Safety Filter: Enhances visualization during procedures for better precision.
• - Multilingual Voice Command: Enables practitioners to control patterns and parameters through voice, further streamlining the operational process.

Feedback from early adopters has been overwhelmingly positive. Dr. Daniel Diaz from Retina Consultants of Miami states, "This innovative device combines the speed and efficiency of pattern laser technology with unparalleled mobility and convenience, setting new standards for indirect laser treatments." The portability and robust pattern options provided by the LYNX™ have significantly enhanced the speed and quality of his retinal treatments.

Commitment to Global Ophthalmology

Founded in Denmark, Norlase is dedicated to revolutionizing eye care through the development of next-generation laser solutions for retinal and glaucoma diseases. With a team of global experts in ophthalmology, laser technology, device development, and customer service, Norlase continues to focus on improving practice efficiency, patient care, and the treatment experience for ophthalmologists worldwide. Other products in their lineup include LEAF, a small laser photocoagulator, and LION, the first fully integrated green laser.

As LYNX™ joins the ranks of its predecessors, it underscores Norlase's goal of making advanced laser technologies accessible to eye doctors around the globe. For more information, visit norlase.com.